STAAR Surgical Company (STAA) News
Filter STAA News Items
STAA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
STAA News Highlights
- For STAA, its 30 day story count is now at 2.
- Over the past 12 days, the trend for STAA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest STAA News From Around the Web
Below are the latest news stories about STAAR SURGICAL CO that investors may wish to consider to help them evaluate STAA as an investment opportunity.
7 Stocks with Strong Insider Buying: December 2023Stocks with strong insider buying should make you curious, and finding them can be a useful shortcut for your research |
Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cutsUnlock the potential of InvestingPro for up to 60% off this Cyber Monday Extended and never miss out on a market winner again. |
Lilian Zhou Appointed to STAAR Surgical Board of DirectorsLAKE FOREST, Calif., December 04, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Lilian Zhou to its Board of Directors, effective December 4, 2023. |
Should Weakness in STAAR Surgical Company's (NASDAQ:STAA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the... |
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)LAKE FOREST, Calif., November 15, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023. |
STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call TranscriptSTAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript November 1, 2023 STAAR Surgical Company beats earnings expectations. Reported EPS is $0.3, expectations were $0.2. Operator: Good day ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical Third Quarter Financial Results Conference Call. During today’s presentation, all parties will be in […] |
Q3 2023 STAAR Surgical Co Earnings CallQ3 2023 STAAR Surgical Co Earnings Call |
Here's What Key Metrics Tell Us About Staar Surgical (STAA) Q3 EarningsWhile the top- and bottom-line numbers for Staar Surgical (STAA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
Staar Surgical Co (STAA) Reports 6% Y/Y Increase in Q3 2023 Net SalesICL Sales Up 13% Y/Y, Marking 23rd Consecutive Quarter of Double-Digit ICL Sales Growth |
STAAR Surgical Reports Third Quarter 2023 ResultsLAKE FOREST, Calif., November 01, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today reported financial results for the third quarter ended September 29, 2023. |